All-In PodcastE13: SPACsgiving Special! Vaccine news, innovation vs regulation, fixing higher ed, challenge trials
CHAPTERS
- 0:00 – 4:20
SPACsgiving kickoff: Metromile goes public and what the company does
The group opens with congratulations for David Friedberg and Chamath on taking Metromile public via SPAC. Friedberg explains Metromile’s pay-per-mile auto insurance model and why connected-car data changes pricing and risk assessment.
- •Friedberg announces Metromile SPAC and gives origin story from 2011
- •Pay-per-mile insurance: mileage is the biggest driver of premium variance
- •How telematics works: OBD device and direct OEM data connections (e.g., Ford)
- •Dynamic pricing future: driving behavior and autonomy-related risk pricing
- 4:20 – 10:57
PIPEs, deal mechanics, and ‘bestie’ investing jealousy
Chamath breaks down what a PIPE is and why it’s used alongside a SPAC. The conversation turns playful as Jason and Sacks complain about being left out and riff on syndicates and angel investing dynamics.
- •Definition of PIPE: private investment in a public enterprise to ‘gross up’ the round
- •Why PIPE investors like it: sponsor sets price/diligence; others join on same terms
- •Chamath’s thesis: machine learning + driving data enables dynamic repricing of risk
- •Running jokes about allocations, unicorns, and an ‘All-In syndicate’ concept
- 10:57 – 15:22
Vaccine breakthroughs and forecasting the end of the pandemic
Jason frames the week’s big story: multiple vaccines posting ~90–95% efficacy and imminent dose availability. Friedberg discusses timelines, herd immunity assumptions, and why markets and conference organizers are suddenly optimistic.
- •Multiple vaccines show high efficacy; near-term manufacturing ramp
- •Operation Warp Speed strategy: parallelize manufacturing before trial completion
- •Estimating population exposure and partial immunity from prior infection
- •Distribution timing and optimism for mid-2021 normalization
- 15:22 – 21:14
NYT on Operation Warp Speed: competence, politics, and credit assignment
Chamath summarizes a New York Times behind-the-scenes account of Warp Speed and argues it makes the Trump administration look surprisingly competent on execution. The group debates how much credit belongs to policy operators vs. politicians and how trial design choices affected election timing.
- •Warp Speed: funding the right players, parallel bets, and cutting red tape
- •mRNA vaccine speed: ‘code in days,’ but trials are the rate limiter
- •Trial diversity requirements delayed Moderna; counterfactual election impact debate
- •Sacks’ point: quiet wonky execution contrasts with Trump’s typical credit-seeking
- 21:14 – 25:12
How mRNA vaccines work and what it means for future pandemics
Friedberg gives a clear explainer on DNA → RNA → proteins and how mRNA vaccines prompt the body to produce viral proteins for immune training. The conversation shifts to what ‘Warp Speed 2.0’ could look like if a deadlier pathogen emerges.
- •mRNA mechanism: deliver RNA instructions so cells produce antigen proteins
- •Why it’s transformative: rapid design from genome sequence
- •Historic concern: unknown side effects of introducing RNA; leap forward in confidence
- •Future implication: vaccine design could be near-instant; trials remain bottleneck
- 25:12 – 31:18
Challenge trials and the ethics of accelerating medical progress
Jason introduces human challenge trials and asks whether it’s ethical to deliberately expose volunteers after vaccination to speed results. The group compares medical risk-taking to other socially sanctioned risks and argues current frameworks are inconsistent and overly paternalistic.
- •Challenge trials vs. Phase 3: speed vs. concentrated participant risk
- •Assumption of risk comparisons: military service, astronauts, extreme sports
- •Argument for volunteer autonomy with informed consent
- •Need for multipath regulatory routes to accelerate cures beyond emergencies
- 31:18 – 35:20
Regulatory capture and hypocrisy: drugs, gambling, and clinical trials
The discussion broadens into regulatory capture: why some harmful activities are permitted while beneficial experimentation is blocked. They critique incentives in FDA/CRO processes and how lobbying and legacy rules can slow innovation and raise costs.
- •‘Nanny state’ inconsistency: hard drugs/gambling allowed, trials restricted
- •Casino negative-EV example vs. restrictions on scientific participation
- •CRO industry critique: compliance bureaucracy can reduce R&D velocity
- •Mexico as contrast for access; U.S. system as expensive ‘protection’ model
- 35:20 – 39:05
Permissionless innovation: why the internet moved fast (and other sectors didn’t)
Chamath argues the internet’s explosive progress came from permissionless innovation—builders didn’t need repeated regulatory approval to ship products. Sacks and Chamath debate whether broad regulatory reform is possible given lobbying and the lack of representation for ‘companies that don’t exist yet.’
- •Permissionless innovation as the core driver of internet-era speed
- •Regulators’ incentives: avoid blame, move slowly, require permission
- •Rewriting outdated frameworks for technology-era realities
- •Lobbying problem: incumbents shape rules; ‘innovation has no lobbyist’
- 39:05 – 46:06
Where deregulation is happening: SEC reforms, gig equity, and accredited investing
Jason points to concrete reforms as proof that some agencies can adapt: changes to accredited investor rules and allowing gig workers to receive equity compensation. Sacks praises SEC leadership and ties reforms to inequality and participation in upside in a zero-rate world.
- •SEC movement: broaden accredited investor access via sophistication/testing
- •Gig worker equity compensation allowance (up to a portion of pay)
- •Sacks’ view: reforms reduce ‘rich stay rich’ dynamic by expanding access
- •Debate: whether Biden era will continue ‘benign’ deregulation trends
- 46:06 – 49:20
Fixing higher ed with Income Share Agreements (ISAs) and vocational pathways
The group argues the bachelor’s degree has become an expensive, low-signal gatekeeping mechanism disconnected from employability. They explore ISAs as a risk-sharing alternative that forces schools to optimize outcomes and placement, potentially unbundling universities into skill-specific programs.
- •ISAs: school/fronting capital gets paid only if graduate earns above a threshold
- •Placement focus: ISA schools spend heavily on job outcomes vs. traditional colleges
- •Trade/vocational respect: Europe-style pathways vs. U.S. credential obsession
- •‘ISA-as-a-service’ idea: infrastructure layer to issue/manage ISAs across schools
- 49:20 – 59:58
Dave Chappelle’s contract dispute as a lesson in power, rights, and ‘bad deals’
Sacks recounts Chappelle’s request to Netflix to remove Chappelle’s Show and uses it to highlight predatory contracts and gatekeeper ecosystems. The group connects Hollywood and music rights issues to broader questions of consent, bargaining power, and when regulation should (or shouldn’t) protect people.
- •Chappelle’s story: contract terms, ownership rights, and leverage over distribution
- •Parallels to music masters (Kanye) and long-tail rights structures
- •Tension: freedom of contract vs. asymmetry and ecosystem ‘collusion’
- •Silicon Valley contrasted as more equity-participatory culture
- 59:58 – 1:06:23
Trump’s (partial) concession, election challenges, and Biden cabinet picks
They interpret Trump’s authorization of transition funds as his closest version of conceding and dissect the collapse of election-fraud narratives. The conversation shifts to Biden’s early cabinet selections, with emphasis on ‘boring competence’ and concerns about monetary policy.
- •GSA transition authorization as de facto acceptance of results
- •Rudy/Sidney Powell legal efforts and the ‘Kraken’ narrative unraveling
- •Biden picks: Yellen for Treasury; experienced, loyal Washington hands
- •Macro concern: money printing, dollar decline, and inflation implications
- 1:06:23 – 1:14:37
Thanksgiving reflections: gratitude, mental health, and what 2021 could bring
Each host shares what they’re thankful for, focusing on family, friendships, and personal growth under lockdown. Jason closes by emphasizing collective problem-solving (vaccines) and greater empathy for mental health struggles, plus optimism for a stronger 2021 recovery.
- •Remote life: more time with kids/family; re-evaluating priorities
- •Sacks on forced introspection and improving personal habits
- •Jason on societal capacity for rapid innovation and coordinated response
- •Mental health: normalizing seeking help; podcast community as a positive outcome
- 1:14:37 – 1:20:13
Middle East peace, energy transition, and ‘character vs. resume’ political outcomes
In the closing stretch, they argue declining strategic reliance on oil and cheaper solar/wind have enabled new Middle East alignments, alongside shared fear of Iran. They debate how Trump achieved major ‘resume’ wins but still lost, attributing it to behavior and polarization.
- •Energy economics: oil decline + renewables shift geopolitics toward détente
- •Kushner’s peace deals credited; broader structural forces debated
- •Middle East sovereign wealth money flows into venture/tech ecosystems
- •Why Trump lost despite ‘wins’: character, communication style, and chaos costs
- 1:20:13 – 1:21:33
Code 13 outro: inside jokes and the final gag
Jason signs off with playful nicknames and ‘bestie deal’ jokes, then the group ends on a crude ‘Code 13’ prank involving a dog video. It’s a light, comedic closer after the heavier policy and pandemic discussion.
- •Wrap-up banter and callbacks to being excluded from deals
- •Planning a ‘deal to exclude the others from’ as a running joke
- •Dog video gag and ‘Code 13’ chant to end the episode
- •Credits-style comedic exit
